z-logo
open-access-imgOpen Access
Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRAS G12C Inhibitor
Author(s) -
Joachim Bröker,
Alex G. Waterson,
Chris A. Smethurst,
Dirk Kessler,
Jark Böttcher,
Moriz Mayer,
Gerhard Gmaschitz,
Jason Phan,
Andrew J. Little,
Jason R. Abbott,
Qi Sun,
Michael Gmachl,
Dorothea Rudolph,
Heribert Arnhof,
Klaus Rumpel,
Fabio Savarese,
Thomas Gerstberger,
Nikolai Mischerikow,
Matthias Treu,
Lorenz Herdeis,
Tobias Wunberg,
Andreas Gollner,
Harald Weinstabl,
Andreas Mantoulidis,
Oliver Krämer,
Darryl B. McConnell,
Stephen W. Fesik
Publication year - 2022
Publication title -
journal of medicinal chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.01
H-Index - 261
eISSN - 1520-4804
pISSN - 0022-2623
DOI - 10.1021/acs.jmedchem.2c01120
Subject(s) - kras , chemistry , in vivo , small molecule , covalent bond , cysteine , binding site , point mutation , mutant , biochemistry , mutation , enzyme , genetics , biology , gene , organic chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom